Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-07

Clinical Trial Update: A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, performance, and bioavailability of entrectinib in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entrectinib (entrectinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2020-09-07